Literature DB >> 10848986

Isolation and characterization of RNA aptamers specific for the hepatitis C virus nonstructural protein 3 protease.

K Fukuda1, D Vishnuvardhan, S Sekiya, J Hwang, N Kakiuchi, K Taira, K Shimotohno, P K Kumar, S Nishikawa.   

Abstract

Nonstructural protein 3 (NS3) from hepatitis C virus (HCV) is a serine protease that provides an essential function in maturation of the virus by cleaving the nonstructural regions of the viral polyprotein. The goal of this work was to isolate RNA aptamers that bind specifically to the NS3 protease active site in the truncated polypeptide DeltaNS3. RNA aptamers were selected in vitro by systematic evolution of ligands by exponential enrichment (SELEX). The RNA pool for SELEX had a 30-nucleotide randomized core region. After nine selection cycles, a pool of DeltaNS3-specific RNA aptamers were obtained. This RNA pool included 45 clones that divided into three main classes (G9-I, II and III). These classes include the conserved sequence GA(A/U)UGGGAC. These aptamers bind to DeltaNS3 with a binding constant of about 10 nM and inhibit approximately 90% of the protease activity of DeltaNS3 and MBP-NS3 (full-length of NS3 fused with maltose binding protein). In addition, these aptamers inhibited approximately 70% of the MBP-NS3 protease activity in the presence of the NS4A peptide P41. G9-I aptamer appeared to be a noncompetitive inhibitor for DeltaNS3 with a Ki approximately 100 nM in the presence of P41. These results suggest that the pool of selected aptamers have potential as anti-HCV compounds. Mutational analysis of the G9-I aptamer demonstrated that the sequences required for protease inhibition are in stem I, stem III and loop III of the aptamer. These regions include the conserved sequence GA(A/U)UGGGAC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848986     DOI: 10.1046/j.1432-1327.2000.01400.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  28 in total

1.  High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.

Authors:  Louisa A Jones; Leighton E Clancy; William D Rawlinson; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 2.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  RNA binding by the NS3 protease of the hepatitis C virus.

Authors:  Robert Vaughan; Yi Li; Baochang Fan; C T Ranjith-Kumar; C Cheng Kao
Journal:  Virus Res       Date:  2012-07-16       Impact factor: 3.303

4.  Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.

Authors:  Qin Pan; Xiao-Lian Zhang; Hong-Yan Wu; Pan-Wen He; Fubin Wang; Ming-Sheng Zhang; Jian-Ming Hu; Bing Xia; Jianguo Wu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

5.  Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors.

Authors:  Victoria Chung; Anthony R Carroll; Norman M Gray; Nigel R Parry; Pia A Thommes; K Claire Viner; Eric A D'Souza
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

Authors:  Gui-Xin Du; Li-Hua Hou; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

8.  Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA.

Authors:  Megumi Tatematsu; Fumiko Nishikawa; Tsukasa Seya; Misako Matsumoto
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Inhibition of HCV NS3 protease by RNA aptamers in cells.

Authors:  Fumiko Nishikawa; Nobuko Kakiuchi; Kohei Funaji; Kotaro Fukuda; Satoru Sekiya; Satoshi Nishikawa
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

Review 10.  The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

Authors:  David N Frick
Journal:  Curr Issues Mol Biol       Date:  2007-01       Impact factor: 2.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.